In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...

Reliance's Strand Life Sciences patents a liquid biopsy platform for early cancer detection using AI and cfDNA analysis in ...

Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

We're on the cusp of a new era in cancer care – one that could dramatically improve survival and quality of life.

For patients here in the commonwealth and across the country, we’re on the cusp of a new era in cancer care — one that could ...

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.